HOME
LUPIN FOUNDATION
CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.
CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers GST Information

Net Sales(₹ Millions)CAGR 15.8%

FY19 (163,694)
FY18 (155,598)
FY17 (171,198)
FY16 (137,579)
FY15 (126,932)

Revenue Compositions (%)

  • North America
  • India
  • APAC
  • EMEA
  • LATAM
  • ROW
  • API
  • NCE

EBITDA (₹ Millions)

FY19 (32,462)
FY18 (32,979)
FY17 (45,997)
FY16 (38,705)
FY15 (38,593)

Profit Before Tax (₹ Millions)

FY19 (18,534)
FY18 (20,076)
FY17 (35,349)
FY16 (33,239)
FY15 (34,148)

Net Profit (₹ Millions)

FY19 (9,466)
FY18 (13,934)
FY17 (25,575)
FY16 (22,607)
FY15 (24,032)

Cumulative R&D (₹ Millions)

Cumulative Capex (₹ Millions)

Dividend (%)

FY19 (250)
FY18 (250)
FY17 (375)
FY16 (375)
FY15 (375)

Earnings Per Share (%)

FY19 (21.00)
FY18 (30.83)
FY17 (56.69)
FY16 (50.45)
FY15 (53.54)

As at March 31, 2019

Note As at 31.03.2019
  in million
As at 31.03.2018
  in million
Assets
Non-Current Assets
a. Property, Plant and Equipment 2 30,672.0 30,272.3
b. Capital Work-in-Progress 9,038.2 8,499.9
c. Intangible Assets 3 3,057.5 3,134.3
d. Intangible Assets Under Development 2,952.7 3,210.5
e. Financial Assets
(i)   Non-Current Investments
-In Subsidiaries 4 51,247.3 51,247.3
– In Others 4 1,563.6 55.3
(ii) Non-Current Loans 5 627.4 616.9
(iii) Other Non-Current Financial Assets 6 14.3 3.2
f. Non-Current Tax Assets (Net) 1,424.1 1,464.3
g. Other Non-Current Assets 7 1,459.9 1,131.5
102,057.0 99,635.5
Current Assets
a. Inventories 8 23,059.8 21,800.2
b. Financial Assets
(i) Current Investments 9 21,073.8 2,325.9
(ii) Trade Receivables 10 37,243.2 49,463.1
(iii)  Cash and Cash Equivalents 11 559.4 1,056.7
(iv) Other Bank Balances 12 55.0 52.9
(v) Current Loans 13 229.1 176.3
(vi)  Other Current Financial Assets 14 6,304.8 4,044.8
c. Current Tax Assets (Net) 2.0
d. Other Current Assets 15 6,318.0 8,168.6
e. Assets Classified as  Held for Sale 59 86.0
94,845.1 87,174.5
Total 196,902.1 186,810.0
Equity and Liabilities
Equity
a. Equity Share Capital 16 905.0 904.2
b. Other Equity 17 170,267.7 156,945.4
171,172.7 157,849.6
Liabilities
Non-Current Liabilities
a. Financial Liabilities
(i) Non-Current Borrowings 18 5.3 40.8
(ii) Trade Payables 19 16.1 31.6
(iii)  Other Non-Current Financial Liabilities 20 149.6 48.3
b. Non-Current Provisions 21 2,094.6 2,062.9
c. Deferred Tax Liabilities (Net) 46 2,662.2 2,583.3
d. Other Non-Current Liabilities 22 827.7 831.4
5,755.5 5,598.3
Current Liabilities
a. Financial Liabilities
(i) Current Borrowings 23 16.8 82.1
(ii) Trade Payables
– Total outstanding dues of Micro Enterprises and Small Enterprises 24 1,046.1 1,063.8
– Total outstanding dues of other  than Micro Enterprises and Small Enterprises 24 11,494.1 13,214.9
(iii)  Other Current Financial Liabilities 25 1,577.2 6,031.3
b. Other Current Liabilities 26 869.8 1,231.9
c. Current Provisions 27 4,903.8 1,470.4
d. Current Tax Liabilities (Net) 66.1 267.7
19,973.9 23,362.1
Total 196,902.1 186,810.0
See accompanying notes forming part of the financial statements

For the year ended March 31, 2019

Note For the Current Year ended 31.03.2019
in million
For the Previous Year ended 31.03.2018
in million
Income
Revenue from Operations 28 113,563.2 100,881.8
Other Income 29 2,913.4 1,311.2
Total Income 116,476.6 102,193.0
Expenses
Cost of Materials Consumed 30 26,930.8 22,595.3
Purchases of Stock-in-Trade 13,470.5 11,301.5
Changes in Inventories of Finished Goods, 31 (1,472.3) 846.7
Work-in-Process and Stock-in-Trade
Employee Benefits Expense 32 15,154.2 14,416.4
Finance Costs 33 354.7 332.4
Depreciation and Amortisation Expense 2&3 4,263.0 3,898.1
Other Expenses 34 30,952.2 30,863.3
Total Expenses 89,653.1 84,253.7
Profit before Exceptional items and Tax 26,823.5 17,939.3
Exceptional item
– Provision for fine (European  Commission) 50 3,399.8
Profit before Tax 23,423.7 17,939.3
Tax Expense 46
– Current Tax (Net) 7,950.0 3,865.7
– Deferred Tax (Net) 85.4 627.0
Total Tax Expense 8,035.4 4,492.7
Profit for the year 15,388.3 13,446.6
Other Comprehensive Income / (Loss)
(A) (i) Items that will not be reclassified subsequently to profit or loss:
(a) Remeasurements of Defined Benefit Liability (16.8) 1.2
(ii) Income tax relating to items that will not be reclassified to profit or loss: 46 6.0 1.0
(B) (i) Items that will be reclassified subsequently to profit or loss:
(a) The effective portion of gain & losses on hedging instruments in a cash flow hedge 15.2 (464.7)
(ii) Income tax relating to items that will be reclassified to profit or loss: 46 0.5 144.8
Other Comprehensive Income / (Loss) for the year, net of tax 4.9 (317.7)
Total Comprehensive Income for the year 15,393.2 13,128.9
Earnings per equity share (in ₹) 43
Basic 34.03 29.76
Diluted 33.89 29.66
Face Value of Equity Share (in ₹) 2.00 2.00
See accompanying notes forming part of the financial statements

For the year ended March 31, 2019

For the Current Year ended 31.03.2019
in million
For the Previous Year ended 31.03.2018
in million
A.  Cash Flow from Operating Activities
Profit before Tax 23,423.7 17,939.3
Adjustments for:
Depreciation and Amortisation Expense 4,263.0 3,898.1
Loss/(Profit) on Sale/Write-off of Property, Plant and Equipment/Intangible Assets (net) (17.7) 26.6
Net Gain on sale of Mutual Fund Investments (122.4) (383.9)
Finance Costs 354.7 332.4
Interest on Deposits with Banks and Others (383.9) (7.5)
Dividend on Mutual Fund Investments (420.9) (274.8)
Unrealised Loss/ (Gain)on Mutual Fund Investments (net) (120.5) (55.4)
Dividend on Non-Current Investment from Subsidiary company (14.5)
Doubtful Trade Receivables / Advances / Deposits written off and provided (net) (63.3) (12.5)
Bad Trade Receivables / Advances / Deposits written off 7.0
Share Based Payments Expense 477.0 643.2
Impairment in value of Non-Current investments 30.1
Provision for fine (European  Commission) 3,399.8
Unrealised Exchange loss / (gain) on revaluation (net) (822.8) 345.7
Operating Cash flows before  Working Capital Changes 29,996.8 22,443.7
Changes in working capital:
Adjustments for (increase) / decrease in operating assets:
Inventories (1,259.6) (543.6)
Trade Receivables 13,161.6 (10,889.4)
Current Loans (52.8) (26.3)
Non- Current Loans (10.5) (81.7)
Other Current Financial Asset (2,104.1) (318.3)
Other Current Asset 1,850.3 (3,464.4)
Other Non-Current Assets 60.2 47.7
Other Non-Current Financial Assets (11.1) 9.2
Adjustments for increase / (decrease) in operating liabilities:
Current Trade Payable (1,809.5) (391.5)
Non-Current Trade Payable (15.5) (13.8)
Other Current Financial liabilities (193.4) (475.8)
Other Current Liabilities (426.0) 634.7
Other Non-Current liabilities (3.7) (221.1)
Other Non-Current Financial liabilities 99.1 (7.4)
Current Provisions 97.5 65.7
Non- Current Provisions (159.0) 229.4
Cash Generated from Operations 39,220.3 6,997.1
Net Income tax paid (8,113.1) (4,902.3)
Net Cash Flow from Operating Activities 31,107.2 2,094.8
B.  Cash Flow from Investing Activities
Capital expenditure, including capital advances (9,709.4) (9,103.8)
Proceeds from sale of Property, Plant and Equipments / Intangible Assets 300.1 13.2
Purchase of Non-Current Investment in subsidiaries (3,283.4)
Purchase of Non-Current Investment in others (1,539.4)
Purchase of Current Investment (89,820.9) (50,214.6)
Proceeds from sale of Current Investments 71,316.2 69,448.0
Bank balances not considered as Cash and Cash Equivalents (net) (2.1) 95.4
Dividend on Mutual Fund Investments 420.9 274.8
Dividend on Non-Current Investment from Subsidiary company 14.5
Interest on Deposits with Banks and others 383.9 7.5
Net Cash Used in Investing Activities (28,650.7) 7,251.6
C.  Cash Flow from Financing Activities
Repayment of Non Current Borrowings (net) (48.1) (49.7)
Proceeds from / (Repayment of) Current Borrowings (net) (65.3) (5,714.1)
Proceeds from issue of equity shares (ESOPs) 0.8 1.0
Securities Premium Received (ESOPs) 36.2 144.2
Finance Costs (164.3) (178.1)
Dividends paid (2,248.4) (3,383.4)
Corporate Tax on Dividend (464.7) (689.7)
Net Cash (Used) / generated in Financing Activities (2,953.8) (9,869.8)
Net (decrease) / Increase in Cash and Cash Equivalents (497.3) (523.4)
Cash and Cash Equivalents as at the beginning of the year 1,056.7 1,580.1
Cash and Cash Equivalents as at the end of the year (refer note 11) 559.4 1,056.7

Notes :

  • The above Cash Flow Statement has been prepared under the ‘Indirect Method’ as set out in the Indian Accounting Standard 7 (Ind AS -7) “Statement of Cash Flow”.
  • Cash comprises cash on hand and current accounts with banks. Cash equivalents are short-term balances (with an original maturity of three months or less from the date of acquisition), current investments that are convertible into known amounts of cash and which are subject to insignificant risk of changes in value.

TEN YEARS FINANCIAL SUMMARY

CONSOLIDATED BALANCE SHEET (₹ in million)

As at March 31, 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
SOURCES OF FUNDS
Shareholders’ funds
Equity Share Capital 889.4 892.4 893.3 895.1 896.8 899.0 901.2 903.2 904.2 905.0
Reserves & Surplus 24,788.9 31,918.4 39,235.6 51,146.7 68,418.9 90,833.3 110,732.5 134,072.5 134,866.4 136,517.3
25,678.3 32,810.8 40,128.9 52,041.8 69,315.7 91,732.3 111,633.7 134,975.7 135,770.6 137,422.3
Non-Controlling Interest 254.9 515.1 722.9 594.5 669.4 241.0 320.8 345.2 400.8 468.6
Loans 11,398.5 11,623.9 16,391.0 11,644.9 6,537.4 5,371.2 71,775.2 79,660.9 71,428.0 84,961.5
Deferred Tax Liabilities (net) 1,630.4 1,791.8 1,910.1 2,336.8 2,486.6 1,527.5 3,266.8 3,948.5 2,855.3 2,882.8
Other Liabilities (incl. Provisions) 11,892.5 14,502.0 20,669.3 22,520.6 23,051.2 33,737.7 39,252.1 47,142.5 52,599.1 53,758.5
TOTAL 50,854.6 61,243.6 79,822.2 89,138.6 102,060.3 132,609.7 226,248.6 266,072.8 263,053.8 279,493.7
APPLICATION OF FUNDS
Fixed Assets
Net Block 15,864.9 17,313.4 22,456.6 24,928.5 26,977.3 27,200.3 64,515.2 87,229.2 79,135.0 87,063.9
Capital Work-in-Progress (incl. Capital Advances) 3,578.7 5,319.3 4,973.7 3,909.0 4,110.2 6,745.3 32,145.5 24,639.0 26,555.6 17,293.9
19,443.6 22,632.7 27,430.3 28,837.5 31,087.5 33,945.6 96,660.7 111,868.2 105,690.6 104,357.8
Goodwill on Consolidation 3,196.8 3,254.9 5,040.0 5,073.2 6,578.7 16,252.8 22,654.4 23,100.1 24,484.9 23,803.2
Investments 264.3 31.5 28.0 20.6 20.6 55.4 143.3 220.0 267.1 317.7
Deferred Tax Assets (net) 195.4 380.5 467.8 704.4 708.1 2,561.7 3,358.5 5,076.4 7,165.6 7,340.0
Other Assets
Inventories 9,714.9 11,999.6 17,326.7 19,489.3 21,294.5 25,036.1 32,736.5 36,422.8 36,624.9 38,367.7
Receivables 11,265.7 12,556.4 17,800.1 21,869.9 24,641.0 26,475.2 45,487.6 43,073.4 51,922.1 51,498.0
Cash & Bank Balances (refer note iii) 2,015.3 4,201.4 4,024.7 4,348.8 9,739.1 21,304.7 8,237.7 28,135.4 16,431.7 32,523.5
Others 4,758.6 6,186.6 7,704.6 8,794.9 7,990.8 6,978.2 16,969.9 18,176.5 20,466.9 21,285.8
27,754.5 34,944.0 46,856.1 54,502.9 63,665.4 79,794.2 103,431.7 125,808.1 125,445.6 143,675.0
TOTAL 50,854.6 61,243.6 79,822.2 89,138.6 102,060.3 132,609.7 226,248.6 266,072.8 263,053.8 279,493.7

TEN YEARS FINANCIAL SUMMARY

CONSOLIDATED STATEMENT OF PROFIT AND LOSS (₹ in million)

Year ended March 31, 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
INCOME
Sales 48,009.5 57,421.7 70,017.2 95,235.3 111,671.2 126,932.2 137,578.7 171,198.0 155,598.4 163,693.7
Other Operating Income 762.5 1,121.5 1,232.1 1,796.7 1,999.3 1,703.0 4,976.7 3,745.3 2,443.1 3,488.1
Other Income 351.1 221.9 143.5 278.5 1,164.8 2,397.5 1,851.9 1,065.1 1,503.5 3,640.2
Total Revenue 49,123.1 58,765.1 71,392.8 97,310.5 114,835.3 131,032.7 144,407.3 176,008.4 159,545.0 170,822.0
EXPENSES
Cost of Materials 19,694.2 22,379.3 26,039.0 35,485.0 38,173.8 41,570.4 43,325.7 50,014.3 52,744.0 58,457.9
Employee Benefits Expense 5,871.5 7,675.6 9,695.3 12,666.2 14,646.5 17,473.4 21,416.2 28,495.2 28,647.1 31,512.9
Manufacturing and Other 13,576.5 16,709.9 21,067.9 26,181.9 30,822.3 33,395.5 40,960.0 51,502.4 45,175.3 48,388.8
Expenses
Total Expenses 39,142.2 46,764.8 56,802.2 74,333.1 83,642.6 92,439.3 105,701.9 130,011.9 126,566.4 138,359.6
Profit before Interest, 9,980.9 12,000.3 14,590.6 22,977.4 31,192.7 38,593.4 38,705.4 45,996.5 32,978.6 32,462.4
Depreciation & Tax
Finance Cost 384.9 344.8 354.7 409.5 266.5 98.1 594.7 1,525.3 2,043.5 3,078.3
Depreciation and Amortisation 1,239.1 1,711.8 2,275.2 3,321.9 2,609.7 4,347.0 4,871.3 9,122.3 10,858.7 10,850.1
Profit before Exceptional 8,356.9 9,943.7 11,960.7 19,246.0 28,316.5 34,148.3 33,239.4 35,348.9 20,076.4 18,534.0
Items & Tax
Exceptional Items (Refer note iv) 14,643.5 3,399.8
Profit before Tax 8,356.9 9,943.7 11,960.7 19,246.0 28,316.5 34,148.3 33,239.4 35,348.9 5,432.9 15,134.2
Current Tax 1,109.8 1,176.3 2,756.2 5,829.0 9,536.0 10,041.6 11,433.5 10,882.1 5,349.8 8,727.0
Deferred Tax 250.4 (26.5) 329.4 12.6 85.5 (337.6) (840.1) (1,097.0) (2,465.2) 289.9
Net Profit before Share of Profit
from Jointly Controlled Entity, 6,996.7 8,793.9 8,875.1 13,404.4 18,695.0 24,444.3 22,646.0 25,563.8 2,548.3 6,117.3
Non-Controlling Interest and
Share of Loss in Associates
Share of Profit from Jointly 49.0 82.5 35.2 37.5
Controlled Entity
Share of Profit attributable to 111.6 148.4 198.6 262.8 331.3 411.9 87.6 71.7 70.9 89.3
Non-Controlling Interest
Share of Loss in Associates 68.8 20.0
Net Profit 6,816.3 8,625.5 8,676.5 13,141.6 18,363.7 24,032.4 22,607.4 25,574.6 2,512.6 6,065.5
Date
Quarter/halfyear/annual
Full year (April-March)
30-09-2019 Q2 FY 2019-2020 Consolidated

Standalone

Unaudited
31-06-2019 Q1 FY 2019-2020 Consolidated

Standalone

Unaudited
31-03-2019 FY 2019 Consolidated

Standalone

Audited
31-12-2018 Q3 2018-2019 Consolidated

Standalone

Unaudited
30-09-2018 Q2 2018-2019 Consolidated

Standalone

Unaudited
30-06-2018 Q1 2018-2019 Consolidated

Standalone

Unaudited
31-03-2018 FY 2018 Consolidated

Standalone

Audited
31-12-2017 Q3 2017-2018 Consolidated

Standalone

Unaudited
30-10-2017 Q2 2017-2018 Consolidated

Standalone

Unaudited

Legend:

Q = Quarterly, H = Half-yearly, FY = Full year

Earnings Call (Kyowa Divestiture)

DOWNLOAD NOW

File size : 203 KB

Earnings Call (Q2 FY 2019-20)

DOWNLOAD NOW

File size : 531 KB

Earnings Call (Q1 FY 2019-20)

DOWNLOAD NOW

File size : 236 KB

Earnings Call (FY 2019)

DOWNLOAD NOW

File size : 275 KB

Earnings Call (Q3 FY 2018-19)

DOWNLOAD NOW

File size : 330 KB

Earnings Call (Q2 FY 2018-19)

DOWNLOAD NOW

File size : 338 KB

Earnings Call (Q1 FY 2018-19)

DOWNLOAD NOW

File size : 354 KB

Lupin Pharmaceuticals, Inc., USA.

2018 | 2019

Kyowa Pharmaceutical Industry Co., Ltd., Japan

2018 | 2019

Pharma Dynamics (Proprietary) Ltd., South Africa

2018 | 2019

Hormosan Pharma GmbH, Germany

2018 | 2019

Multicare Pharmaceuticals Philippines, Inc., Philippines

2018 | 2019

Generic Health Pty Ltd., Australia

2018 | 2019

Kyowa CritiCare Co., Ltd., Japan

2018 | 2019

Lupin Holdings B.V., Netherlands

2018 | 2019

Lupin Atlantis Holdings SA, Switzerland

2018 | 2019

Lupin Healthcare (UK) Ltd

2018 | 2019

Lupin Australia Pty Ltd., Australia

2018 | 2019

Lupin Pharma Canada Ltd., Canada

2018 | 2019

Lupin Mexico S.A. de C.V., Mexico

2018 | 2019

Bellwether Pharma Pty Ltd., Australia

2018 | 2019

Lupin Philippines, Inc., Philippines

2018 | 2019

Lupin Healthcare Ltd., India

2018 | 2019

Generic Health SDN. BHD., Malaysia

2018 | 2019

Lupin Middle East FZ-LLC, Dubai

2018 | 2019

Lupin Inc., USA.

2018 | 2019

Lupin GmbH, Switzerland

2018 | 2019

Nanomi B.V., the Netherlands

2018 | 2019

Laboratorios Grin, S.A. de C.V., Mexico

2018 | 2019

Medquimica Industria Farmaceutica LTDA, Brazil

2018 | 2019

Gavis Pharmaceuticals, LLC, USA. (up to March 26, 2019)

2018 

Novel Laboratories, Inc., USA.

2018 | 2019

Lupin Research Inc., USA.

2018 | 2019

Lupin Pharma LLC, Russia

2018 | 2019

Lupin Ukraine LLC, Ukraine (up to February 7, 2019)

2018 

Lupin Latam Inc., USA

2018 | 2019

Lupin Japan & Asia Pacific K.K. Japan

2018 | 2019

Lupin IP Ventures Inc., USA

2018 | 2019

Sybiomix Therapeutics, LLC, USA

2018 | 2019

Lupin Europe GmbH, UK

2018 | 2019

YL Biologics Ltd., Japan (Joint Venture)

2018 | 2019

ANNUAL GENERAL MEETING

The 37th Annual General Meeting of Lupin Limited
Rang Sharda Natyamandir, Bandra Reclamation, Bandra West, Mumbai 400050
7th August 2019 (Wednesday) at 2.30 pm
FINANCIAL CALENDAR
Investor’s Call Japan (12th November, 2019) – EARNINGS CALL
Q2 FY 2020 (6th November, 2019)
Q1 FY 2020 (8th August, 2019)
Q4 FY 2019 (15 May, 2019)
Q3 FY 2019 (6 February, 2019)
Q2 FY 2019 (31 October, 2018)
Q1 FY 2019 (8 August, 2018)

INVESTOR MEETS/EARNINGS CALL

FY 2017-18
Q4 FY 2019 (15 May, 2019)
Q3 FY 2019 (6 February, 2019)
Q2 FY 2019 (31 October, 2018
Q1 FY 2019 (8 August, 2018)